24, 2011 that it would allow state Medicaid programs to reimburse the delivery of evidencebased quitline counseling and operations costs as an administrative expense at a 50% match rate, and encouraged states to actively promote the availability of quitline and other CMScovered quit smoking treatment benefits. <http://www.naquitline.org/news/67417/Centersfor-Medicare--Medicaid-Announces-a-Series-of-Changes-totheir-Coverage-for-Tobacco-
Cessation.htm>
To maximize the public health impact of these new policies, whenever they go into effect, we need planned, proactive research. This includes monitoring and evaluating (1) including 1-800-QUIT-NOW number on the FDA's new graphic warning labels, and (2) increasing CMS coverage of state quitline services. The SBM and SRNT research communities are uniquely positioned to take a leading role in designing and conducting this research --to strengthen early FDA and HHS policy implementation and impact.
Additional Background:
The toll-free 1-800-QUIT-NOW national quitline portal, which connects callers with their state quitlines, was selected for FDA's new warning labels as the single most accessible source of unbiased, evidence-based quitting information and assistance available to smokers in the US.
In fiscal year 2010, state quitlines received nearly one million calls addressing education about treatment options, problem-solving and logistical assistance, and direct enrollment into treatment services. Nearly 500,000 smokers enroll in quitline treatment each year. 1 Quitline services greatly increase the chances that a smoker will quit and are provided free of charge.
The 2010 NAQC Annual Survey of Quitlines 1 indicated that the 1-800-QUIT-NOW portal provides unprecedented levels of access to evidence-based quitline services, which also have been shown to successfully reach many underserved and high-risk groups who suffer a disproportionate burden of tobacco-caused death and disease.
Existing international studies demonstrate that warning labels that effectively communicate the risks of smoking, increase quitting motivations, intentions and attempts, and that smokers who perceive greater smoking-related health hazards are more likely to consider quitting, attempt to quit, and quit. 2, 3, 4 Combining new warning labels with the 1-800-QUIT-NOW number and quitline promotions is likely to generate similar synergistic impacts in quit motivation, attempts and successes, and to reduce disparities. The research community must be able to act whenever the courts permit the FDA warnings to go into effect.
In sum, the new FDA rule combined with expanded Medicaid coverage for quitline services has brought us to a watershed moment for reducing tobacco use and its disparities and harms in the U.S., with lessons for other nations as well.
Recommendations
SBM and SRNT join together to urge policy makers to support adequate quitline service funding to handle increased call volume and assure that callers receive appropriate services.
We also urge strong research leadership and funding for research to monitor, evaluate and maximize the public health benefits. The SBM and SRNT research communities should act now to advance research efforts, producing results that can inform early FDA and HHS policy implementation and creating ongoing feedback to assess and help assure success of these policies.
The time between now and whenever the new FDA warning labels are scheduled to appear in retail outlets, provides an important "window of opportunity" to support and implement funding and research.
Research and evaluation will require more frequent surveys of smokers' quit attempts, methods and results, and provider quit smoking treatment and quitline referral rates, as well as ongoing surveillance of quitline services and promotions, and state support for quitline services, including pre-implementation baseline studies and annual updates and public reports (e.g.,
MMWR, DHHS CMS, and NAQC).
Leaders and members of SBM's and SRNT's international affiliates can help facilitate crossborder learning -especially given the large number of countries that already have included quitline service numbers on their graphic warning labels. Much could be learned, for instance, by collaborating in real time with Canada's planned study of how adding a quitline number to their existing graphic warning labels affects: (a) quitline reach, and reach equity; (b) populationwide and subgroup quit rates; (c) health professional quitline referrals; and (d) quitline operations, costs and service protocols.
FDA's historic rule on cigarette warning labels, and CMS' provision of matching funds for state quitline services and quitline coverage for Medicaid beneficiaries, together provide a new public health opportunity to reduce the death and disease toll from tobacco use. Adequate funding to achieve that goal, together with strong science-based leadership and advocacy, are essential for
